As we just dealt with improving male sexual response, it’s now the ladies’ turn (and we’ll pass up the obvious joke opportunities…).  You may have heard that an FDA panel has recommended approval of the drug Flibanserin, popularly known as Female Viagra.  Which sounds great. Except, as as this article from Vox explains, the drug offers very minimal results (one additional “sexually satisfying event” per month) with a pretty high chance of side effects (low blood pressure, dizziness, fainting).  Critics call the whole thing a marketing ploy by Big Pharma, just looking for a new product to sell.